LMR Partners LLP Purchases New Position in Select Medical Holdings Co. (NYSE:SEM)

LMR Partners LLP bought a new position in Select Medical Holdings Co. (NYSE:SEM) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 176,061 shares of the health services provider’s stock, valued at approximately $6,139,000. LMR Partners LLP owned 0.14% of Select Medical as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in SEM. Hexagon Capital Partners LLC boosted its stake in shares of Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 645 shares in the last quarter. Transcendent Capital Group LLC acquired a new stake in Select Medical during the second quarter worth about $35,000. Canada Pension Plan Investment Board acquired a new stake in shares of Select Medical during the second quarter valued at about $39,000. DekaBank Deutsche Girozentrale acquired a new position in Select Medical in the 2nd quarter valued at about $60,000. Finally, GAMMA Investing LLC increased its holdings in Select Medical by 52.8% during the 2nd quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider’s stock worth $70,000 after purchasing an additional 685 shares during the period. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Performance

Shares of NYSE SEM opened at $36.62 on Tuesday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The stock has a 50 day moving average price of $34.81 and a 200 day moving average price of $34.82. The stock has a market capitalization of $4.74 billion, a PE ratio of 17.11, a price-to-earnings-growth ratio of 1.95 and a beta of 1.42. Select Medical Holdings Co. has a 52 week low of $22.26 and a 52 week high of $40.98.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. During the same quarter in the prior year, the firm earned $0.46 EPS. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. Analysts predict that Select Medical Holdings Co. will post 2.16 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th will be paid a dividend of $0.125 per share. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.37%. Select Medical’s dividend payout ratio (DPR) is currently 23.36%.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Benchmark reaffirmed a “buy” rating and set a $48.00 price objective on shares of Select Medical in a research note on Friday, November 1st. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 13th. Bank of America assumed coverage on shares of Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target for the company. Finally, Royal Bank of Canada lifted their price target on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $40.75.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.